SUMMARY Plasma glutathione S-transferase (GST) measurements have been used to study early changes in hepatocellular integrity after paracetamol overdose and treatment with Nacetylcysteine (NAC). Patients admitted within seven hours and successfully treated had raised or equivocal GST on admission and each showed a transient peak in GST approximately 12 hours after the overdose. Similar, though smaller changes in GST, were seen in untreated patients whose paracetamol level fell below the treatment line. The plasma GST concentrations in successfully treated patients were small compared with values found in patients who subsequently developed severe liver damage. The changes in GST concentration observed in patients who developed severe liver damage indicated that distinct early and late phases of paracetamolinduced hepatotoxicity occurred. Although the mechanism by which paracetamol exerts its early toxic effect is unclear, our data suggest that prompt treatment with NAC can successfully prevent both clinical and subclinical hepatotoxicity in this early period.
evidence of acute liver damage becomes evident approximately 12 hours after the overdose but maximal abnormalities of liver function tests, particularly aspartate and alanine aminotransferase (AST and ALT) activity do not occur for two to four days. 10 The degree of liver damage is usually assessed by the plasma AST or ALT activity and severe liver damage is regarded as being present when plasma ALT or AST exceeds 1000 IU/1. In patients with moderate or mild degrees of paracetamol-induced hepatocellular damage, aminotransferase measurements may not reflect accurately the histological severity of liver damage. 1' In contrast with AST, plasma concentrations of glutathione S-transferase (GST) correlate significantly with histology in patients with chronic active hepatitis. 12 The high concentration of GST in human liver cytosol and their small size (45 000/ 50 000 Da)13 suggest that plasma GST concentrations should provide a very sensitive index of hepatocellular integrity because after cellular damage, GST would be expected to be released quickly and in considerable quantity. Preliminary work has suggested that this is so.14 5 ments to investigate the time course of hepatocellular damage in patients admitted after paracetamol overdose.
Methods

PATIENTS
Nineteen patients with paracetamol poisoning were studied. Seven did not require treatment and seven others were given NAC within eight hours of the overdose. Two patients were treated between 13 and 16 hours and three patients who presented after 17 hours were not treated. The alcohol intake before the overdose was noted in all patients. The plasma paracetamol concentrations and the ingestion treatment interval for each of the patients is shown in the Table. The treatment regime involved administering 300 mg/kg of NAC intravenously over a period of 20 hours. 6 The first 150 mg/kg was given in 200 ml of 5% dextrose over 15 minutes followed by a 50 mg/kg dose in 500 ml of 5% dextrose over 4 hours and the two further 50 mg/kg doses each in 500 ml of 5% dextrose over the next two eight hour periods.
Blood (10 ml) was taken on admission and at frequent intervals until discharge. In four patients blood was taken at 30 minute intervals for the first 14 hours after the initial rapid infusion of NAC.
The plasma was assayed for ALT using a Sequential Multiple Analysis with Computer System (SMAC), Technicon Treated -early presentation showed raised GST concentrations had taken no alcohol before the overdose.
Normal activities of ALT were found in all samples from all these patients (Table) .
Late presentation (>17 hours after overdose) Three patients presented more than 17 hours after paracetamol overdose and each subsequently suffered severe liver damage with ALT activities >1000 IU/l ( Fig. 2 ; Table) . Each patients had GST concentrations on admission which were in excess of 150 times the upper limit of the reference range. In contrast ALT activities were no greater than 20 times the upper limit of the reference range. Each patient had raised but relatively stable GST concentrations (at 100-200 times the upper limit of the reference range) for a number of hours after admission. Between 38 hours and 45 hours, however, a further increase in GST concentrations occurred in two patients, with peak GST concentrations occurring between 50 hours and 70 hours. Peak concentrations of GST preceded peak activities of ALT by appoximately five hours to 10 hours and the relative magnitude of the abnormality of GST at these peak concentrations was between 10 and 30 times greater than for ALT. The fall in GST was far more rapid than the fall observed in ALT concentrations. TREATMENT 
GROUP
Early presentaion (<7 hours after overdose)
Each of the seven patients in this group had raised or equivocal GST on admission and all showed a peak in GST between six and 12 hours after the overdose (Figs. 3 and 4) . In all but two cases GST returned to normal within 24 hours. Only one patient admitted to consuming a large quantity of alcohol before taking the overdose. Three patients developed small abnormalities in ALT and AST which peaked 12 to 19 hours after the overdose.
Two of the seven patients had half-hourly blood samples taken in the period immediately after the rapid infusion of NAC, and each showed a marked rise in GST concentration in the first postinfusion sample (Fig. 4) . These abnormalities in GST rapidly reverted to normal. No abnormality in ALT or AST was seen in any sample taken from these two patients.
Late presentation (12-15 hours after overdose) Two patients who presented 12 and 15 hours after overdose were treated with NAC. In each of these patients the admission and subsequent GST concentrations were similar to those seen in the late presentation-untreated group. In both patients NAC treatment did not prevent liver damage and a large increase in GST and ALT was observed.
Changes in GST concentrations appeared to occur in both patients after NAC infusion (Fig. 2) . In one patient increased GST was observed in the first postinfusion sample and a peak in GST was observed one and half hours later.
The changes in GST observed in the second patient were more difficult to interpret. In this patient GST did not rise in the first postinfusion sample but in the following hour there was a large rapid increase in GST. This patient quickly developed severe liver damage as shown by the rising ALT activities. The concentrations of GST also continued to rise, but a significant decrease in the rate of change of GST was observed one and a half hours after NAC infusion (Fig. 2) . Our data, therefore, suggest that after a paracetamol overdose, in untreated patients, there are two distinct phases of hepatotoxicity. There is an early phase characterised by small abnormalities in plasma GST which occur within four hours and progress to more moderate abnormalites in plasma GST (approximately 100 times the upper limit of the reference range) by 40 hours. There then follows a second phase of hepatotoxicity characterised by severe liver damage and plasma GST concentrations in excess of 1000 times the upper limit of the reference range. The possibility of early liver .damage in patients taking a paracetamol overdose was first suggested by Prescott et al who noted that the plasma half life of paracetamol was prolonged from the outset in such patients.16
The early release of GST may be because of mild diffuse hepatocellular damage or may reflect damage to a specific population of cells which are more vulnerable to paracetamol. This putative increased vulnerability may be because of the increased concentrations of P450, subnormal intracellular concentrations of reduced glutathione or reduced conjugating ability. Whatever the cause, our data indicate that NAC treatment can arrest the early phase and prevent the late phase of paracetamol-induced hepatotoxicity.
The rise in plasma GST which we observed within 30 minutes of NAC infusion may have been coincidental and caused solely by paracetamol toxicity but the time course of the rise in GST suggests that NAC treatment may itself result in a release of a small amount of GST from the hepatocyte in to plasma. Studies on isolated rat hepatocytes tend to support this view because high concentrations of cysteine, the active metabolite of NAC, can produce cytotoxicity and leakage of intracellular enzymes. 7 In man clarification of this point by control experiments -that is, NAC infusion in the absence of paracetamol poisoning and no NAC infusion after a paracetamol overdose, in patients requiring treatment and admitted within 8 hours -would be unethical. Comparison of peak GST values found in severe paracetamol-induced liver damage with peak values found in successfully treated patients indicates, however, that any liver damage resulting from NAC infusion is, clinically, insignificant.
It should be noted that GST is present in renal tissue in a concentration similar to that found in liver. 18 It is likely, therefore, that a small percentage of the GST we have measured in plasma is of renal origin.
In conclusion, although the mechanism by which paracetamol exerts an early toxic effect on the liver is unclear, our data suggest that prompt treatment with NAC can successfully prevent both clinical and subclinical hepatotoxicity in this early period. It would be useful to ascertain whether methionine, the other commonly used treatment for paracetamol overdose7 8 is as effective at preventing this early toxicity. Our data also show the sensitivity and potential which plasma GST measurements have in investigating, non-invasively, hepatotoxicity hepatocellular damage. 
